Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
2.68 EUR | +4.89% | +14.04% | +2.29% |
May. 14 | Transcript : Innate Pharma S.A., Q1 2024 Earnings Call, May 14, 2024 | |
Apr. 15 | Sanofi: progress in hematology trial | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.29% | 224M | |
+44.48% | 55.07B | |
+43.85% | 40.22B | |
-0.86% | 41.79B | |
-7.59% | 28.17B | |
+12.30% | 26.28B | |
-21.83% | 18.93B | |
+7.15% | 13.03B | |
+29.40% | 12.26B | |
+25.15% | 12.21B |
- Stock Market
- Equities
- IPH Stock
- News Innate Pharma
- US FDA Ends Partial Clinical Hold on Innate Pharma's Investigational Cancer Drug